News Brief
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: Report
Swarajya Staff
May 12, 2021, 08:42 AM | Updated 08:42 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The subject expert panel (SEC) of India's drug regulator has reportedly recommended for grant of permission to Bharat Biotech to conduct phase 1 and 2 trials of is Covid-19 vaccine Covaxin on non-adults between 2-18 years of age.
Bharat Biotech has developed the Covaxin, which is India's first indigenous Covid-19 vaccine, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
The Covaxin had been approved for emergency use in those aged above 18 years in January and is currently being used in Covid-19 vaccination drive across India.
"Bharat Biotech's Covid-19 vaccine Covaxin recommended by expert panel for phase 2 and 3 clinical trials on 2 to 18 year-olds" sources were quoted by PTI as saying.
Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources
— Press Trust of India (@PTI_News) May 11, 2021
It should be noted that Bharat Biotech had earlier last month announced that the Covaxin has demonstrated overall Interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease as per the interim results of the Phase 3 clinical trials of the vaccine.
The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 10 per cent over the age of 60, with analysis conducted 14 days post second dose, the company said.
So far, three Covid-19 vaccines - Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russian Sputnik V - have been approved in India for emergency use.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.